| scholarly article | Q13442814 |
| P50 | author | Robert S Sandler | Q87015965 |
| Til Stürmer | Q88268207 | ||
| Jennifer L. Lund | Q89058482 | ||
| Hanna K Sanoff | Q89113920 | ||
| M Alan Brookhart | Q95597164 | ||
| Joan L. Warren | Q125599790 | ||
| P2093 | author name string | Linda C Harlan | |
| P2860 | cites work | Sample size calculation should be performed for design accuracy in diagnostic test studies | Q47375214 |
| Acute Myeloid Leukemia After Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk | Q63365930 | ||
| Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer | Q63365966 | ||
| Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer | Q79320537 | ||
| Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort | Q79748458 | ||
| Racial disparities in treatment and survival of male breast cancer | Q79975628 | ||
| The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer | Q80353279 | ||
| Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer | Q82999159 | ||
| Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women | Q83048492 | ||
| Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer | Q83857361 | ||
| Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer | Q83946997 | ||
| Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population | Q30714715 | ||
| Utility of the SEER-Medicare data to identify chemotherapy use. | Q30714828 | ||
| Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data | Q31109905 | ||
| Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer | Q33946721 | ||
| Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer | Q34307949 | ||
| Construct validity of medicare chemotherapy claims: the case of 5FU. | Q34553407 | ||
| Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer | Q34815323 | ||
| Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population | Q35011194 | ||
| Completion of therapy by Medicare patients with stage III colon cancer | Q35071455 | ||
| Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. | Q36060162 | ||
| Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants | Q36200748 | ||
| External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews | Q36936083 | ||
| Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer | Q37122045 | ||
| Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer | Q37158881 | ||
| Temporal trends in the management of potentially resectable lung cancer | Q37171182 | ||
| Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer | Q37171293 | ||
| Residual treatment disparities after oncology referral for rectal cancer | Q37398534 | ||
| Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women | Q37408456 | ||
| Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy | Q39785729 | ||
| American Society of Clinical Oncology guidance statement: the cost of cancer care | Q39965070 | ||
| Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer | Q43175195 | ||
| Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer | Q43222294 | ||
| Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy | Q43708111 | ||
| Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. | Q45947940 | ||
| Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer | Q46332611 | ||
| P433 | issue | 5 | |
| P921 | main subject | Medicare | Q559392 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | e27-34 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Medical Care | Q15762119 |
| P1476 | title | Identifying specific chemotherapeutic agents in Medicare data: a validation study | |
| P478 | volume | 51 |
| Q31144976 | A Validation Study of Administrative Claims Data to Measure Ovarian Cancer Recurrence and Secondary Debulking Surgery |
| Q30992942 | Accuracy of using Diagnosis Procedure Combination administrative claims data for estimating the amount of opioid consumption among cancer patients in Japan |
| Q89747101 | Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case-Control Study |
| Q37644543 | Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study |
| Q90664127 | Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era |
| Q34978347 | Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients |
| Q36598736 | Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer |
| Q43508505 | Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer |
| Q36913615 | Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy |
| Q91792040 | Comparison of Medicare Claims-based Proxy Measures of Poor Function and Associations With Treatment Receipt and Mortality in Older Colon Cancer Patients |
| Q30779910 | Comparison of SEER Treatment Data With Medicare Claims |
| Q94466980 | Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use |
| Q91723892 | Diagnostic Assessment of Assumptions for External Validity: An Example Using Data in Metastatic Colorectal Cancer |
| Q44361470 | Do community-based patient assistance programs affect the treatment and well-being of patients with breast cancer? |
| Q37627696 | Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study |
| Q35602510 | Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse |
| Q55137369 | Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival. |
| Q88813536 | Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine |
| Q35748060 | Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States |
| Q100954147 | Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer |
| Q37365689 | Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry |
| Q36869758 | Intended versus inferred management after PET for cancer restaging: analysis of Medicare claims linked to a coverage with evidence development registry |
| Q34055498 | Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage. |
| Q34280296 | Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database |
| Q36824126 | Patterns of Colorectal Cancer Care in the United States: 1990-2010. |
| Q36761488 | Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients |
| Q31035145 | Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data |
| Q93037136 | Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis |
| Q39808566 | Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women |
| Q38174422 | Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients. |
| Q55005151 | The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. |
| Q36280941 | The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes |
| Q39532324 | Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab |
| Q33846793 | Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database |
| Q36200205 | Trends in Anemia Management in Hemodialysis Patients with Cancer |
| Q57822900 | Trends in Antineoplastic Receipt after Medicare Payment Reform: Implications for Future Oncology Payment Design |
| Q50075321 | Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies |
| Q37164131 | Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is high |
| Q36852163 | Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer |
Search more.